143 related articles for article (PubMed ID: 7017048)
41. Biosynthesis of bile acids in man. Hydroxylation of the C27-steroid side chain.
Björkhem I; Gustafsson J; Johansson G; Persson B
J Clin Invest; 1975 Mar; 55(3):478-86. PubMed ID: 1117065
[TBL] [Abstract][Full Text] [Related]
42. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
Kuramoto T; Suemura Y; Kihira K; Hiraoka T; Hoshita T
Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780
[TBL] [Abstract][Full Text] [Related]
43. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
Batta AK; Salen G; Shefer S; Tint GS; Batta M
J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
[TBL] [Abstract][Full Text] [Related]
44. Formation of bile acids in man: conversion of cholesterol into 5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol in liver homogenates.
Björkheim I; Danielsson H; Einarsson K; Johansson G
J Clin Invest; 1968 Jul; 47(7):1573-82. PubMed ID: 4385432
[TBL] [Abstract][Full Text] [Related]
45. Inborn errors of bile acid metabolism.
Clayton PT
J Inherit Metab Dis; 1991; 14(4):478-96. PubMed ID: 1749214
[TBL] [Abstract][Full Text] [Related]
46. Biochemical studies of inherited diseases related to abnormal cholesterol metabolism. I. High-performance liquid chromatographic analysis of bile alcohol glucuronides in cerebrotendinous xanthomatosis.
Ohshima A; Kuramoto T; Hoshita T
Biol Pharm Bull; 1994 May; 17(5):721-3. PubMed ID: 7920441
[TBL] [Abstract][Full Text] [Related]
47. 7 beta-hydroxy bile alcohols: facile synthesis and 2D 1H NMR studies of 5 beta-cholestane-3 alpha, 7 beta, 12 alpha, 25-tetrol.
Dayal B; Ertel NH; Padia J; Rapole KR; Salen G
Steroids; 1997 May; 62(5):409-14. PubMed ID: 9178427
[TBL] [Abstract][Full Text] [Related]
48. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Une M; Kibe A; Itoga E; Kito S; Kuramoto T
J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799
[TBL] [Abstract][Full Text] [Related]
49. Metabolism of the cholestanol precursor cholesta-4,6-dien-3-one in different tissues.
Buchmann MS; Björkhem I; Skrede S
Biochim Biophys Acta; 1987 Nov; 922(2):111-7. PubMed ID: 3676336
[TBL] [Abstract][Full Text] [Related]
50. Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study.
Dayal B; Salen G; Tint GS; Toome V; Shefer S; Mosbach EH
J Lipid Res; 1978 Feb; 19(2):187-90. PubMed ID: 632682
[TBL] [Abstract][Full Text] [Related]
51. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of potential C27-intermediates in bile acid biosynthesis and their deuterium-labeled analogs.
Shoda J; Axelson M; Sjövall J
Steroids; 1993 Mar; 58(3):119-25. PubMed ID: 8475516
[TBL] [Abstract][Full Text] [Related]
53. ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis.
DeBarber AE; Connor WE; Pappu AS; Merkens LS; Steiner RD
Clin Chim Acta; 2010 Jan; 411(1-2):43-8. PubMed ID: 19808031
[TBL] [Abstract][Full Text] [Related]
54. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis.
Kihira K; Kubota A; Hoshita T
J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531
[TBL] [Abstract][Full Text] [Related]
55. Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study).
Dayal B; Tint GS; Shefer S; Salen G
Steroids; 1979 Mar; 33(3):327-38. PubMed ID: 442127
[TBL] [Abstract][Full Text] [Related]
56. Quantitative aspects of the conversion of 5 beta-cholestane intermediates to bile acids in man.
Schwartz CC; Cohen BI; Vlahcevic ZR; Gregory DH; Halloran LG; Kuramoto T; Mosbach EH; Swell L
J Biol Chem; 1976 Oct; 251(20):6308-14. PubMed ID: 185209
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
[TBL] [Abstract][Full Text] [Related]
58. Rabbit liver contains one major sterol 12alpha-hydroxylase with broad substrate specificity.
Andersson U; Eggertsen G; Björkhem I
Biochim Biophys Acta; 1998 Jan; 1389(2):150-4. PubMed ID: 9461256
[TBL] [Abstract][Full Text] [Related]
59. Screening for cerebrotendinous xanthomatosis by using an enzymatic assay for 7 alpha-hydroxylated steroids in urine.
Koopman BJ; Van der Molen JC; Wolthers BG; Waterreus RJ
Clin Chem; 1987 Jan; 33(1):142-3. PubMed ID: 3542288
[TBL] [Abstract][Full Text] [Related]
60. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
Buchmann MS; Björkhem I; Lund AM; Skrede S
Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
